Please assess the completion status of the following clinical trial:

Trial Title: Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV-1 infected children~* Weight over 12 kgs~* Age over 30 months~* Clinical stage requiring HAART~* Naive to antiretroviral treatment (except PMTCT prophylaxis)~* Mother's or tutor's informed consent signed~Exclusion Criteria:~* HIV-2 or dual HIV infection~* Previous antiretroviral therapy~* Children unable to swallow pills~* Known resistance to non-nucleoside reverse transcriptase inhibitor (NNRTI)

- Gender: ALL
- Minimum Age: 30 Months
- Maximum Age: 15 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).